This Minneapolis office tower has gone from bargain sale to trailblazer

Why this matters

Office continues to trade in two distinct markets: trophy assets in walkable submarkets that are leasing at or near record rents, and commodity Class B and C buildings where the basis is still resetting. Underwriting on the latter has moved toward replacement-cost-minus, with credit underwriting now leaning on tenant covenant and remaining lease term rather than mark-to-market expectations. Minneapolis medical office and industrial continue to outperform. Multifamily supply has cooled meaningfully entering 2026 and concessions are now retracing. For LP-positioned capital, the read-through is that the bifurcation is now a structural feature of the sector, not a cycle to wait out.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

• The sixth Minneapolis story tracked on the wire in August 2026. All Minneapolis coverage →
• Disclosed office deal value tracked in August 2026: $17.1B across 72 reported transactions. All Office coverage →

Computed from Real Estate Trail’s own tracked coverage

External link. Real Estate Trail does not republish source content.